Using a similar strategy, we identified 14 IDH-mutant astrocytomas with prior evidence of CIN by at least two detection methods and 28 with no evidence of CIN, and performed methylation profiling to separate these cases into two distinct clusters based on the most differently methylated probes [62]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).